PSNL.NASDAQPersonalis, INC

Form 4: Personalis Director Bloom Granted Stock Options

Sentiment:

SEC Form 4 Filing


Olivia Kyusuk Bloom, a director at Personalis, Inc., was granted stock options to purchase 50,000 shares of common stock on May 16, 2025.

Summary

  • Olivia Kyusuk Bloom, a director of Personalis, Inc. (PSNL), filed a Form 4 on May 20, 2025.
  • The filing reports a transaction that occurred on May 16, 2025, where Bloom was granted stock options to purchase 50,000 shares of Personalis common stock.
  • The exercise price of the stock options is $4.95 per share.
  • The options vest on the earlier of the one-year anniversary of the grant date or the day prior to the company's next annual meeting of stockholders occurring after the grant date, contingent upon continuous service.
  • The options also vest immediately prior to a Change in Control event.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The granting of stock options is generally viewed as a positive sign, aligning director interests with shareholders, but it's a routine event.

Positives

  • The granting of stock options to a director aligns their interests with those of the shareholders.
  • The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

  • Granting stock options to directors is a standard practice in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
  • The vesting schedule described is typical, often tied to continued service and/or company performance milestones.
  • The specific terms of the option grant (number of shares, exercise price, vesting schedule) would need to be compared to peer companies to assess its competitiveness.

Stakeholder Impact

  • Shareholders may view the granting of stock options as a positive sign, aligning the director's interests with the company's success.
  • The director is incentivized to contribute to the company's growth and profitability to increase the value of their stock options.

Key Dates

DateDescription
05/16/2025Date of the transaction: Olivia Kyusuk Bloom was granted stock options.
05/20/2025Date of the Form 4 filing.
05/16/2035Expiration date of the stock options.

Keywords

Form 4, stock options, Personalis, PSNL, director, Olivia Kyusuk Bloom, beneficial ownership, equity incentive plan, Change in Control

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.